http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108686226-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6929 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-549 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2018-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108686226-B |
| titleOfInvention | Nano-drug delivery system using basic group as carrier |
| abstract | The invention provides a nano-drug delivery system taking basic groups as carriers, which comprises drugs and carriers, wherein the drugs are purine or pyrimidine similar drugs, and the carriers are basic groups; the drug and the carrier form a nano assembly through non-covalent bond action. The nano-drug delivery system provided by the invention takes endogenous substance bases as carriers, is formed by assembling through hydrogen bonds and utilizing hydrophilicity and hydrophobicity. The nano-drug delivery system has the advantages of non-toxic carrier, high drug loading and simple preparation process, and can be industrially produced and clinically popularized. |
| priorityDate | 2018-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 95.